The Abu Dhabi Investment Office (ADIO) has  announced on Thursday plans to expand operations of its office in San Francisco to support the global expansion of Abu Dhabi’s economic clusters. At an epicentre of health tech, biotech, and venture capital, the expansion of the San Francisco office will promote Abu Dhabi’s fast-track clinical validation and regulatory pathways to serve as a launchpad for global innovation in healthcare, as well as other priority sectors.

The Abu Dhabi’s Health, Endurance, Longevity and Medicine cluster (HELM), launched in April 2025 by the Abu Dhabi Department of Economic Development (ADDED) and ADIO in partnership with the Department of Health – Abu Dhabi, is projected to contribute $25.6 billion to Abu Dhabi’s GDP, create 30,000 new jobs, and attract $11.5 billion in investment by 2045.

The Cluster, capitalizing on growth opportunities in the global healthcare market, which is projected to reach $25.3 trillion by 2045, will be a central focus for the San Francisco office. As one of the largest global health innovation initiatives, HELM leverages Abu Dhabi’s strengths in genomics, population health intelligence, AI in healthcare, and regulatory agility. The ADIO office will enable US-based startups and scaleups to join leading US healthcare firms, such as Insilico Medicine and Innovaccer, in expanding to Abu Dhabi.

The announcement was made during a high-level delegation visit to San Francisco, led by H.E. Mansoor Ibrahim Al Mansoori, chairman of the Department of Health – Abu Dhabi, to strengthen strategic partnerships and hold meetings with decision-makers, entrepreneurs, and representatives of leading institutions in the health technology and innovation sector in the region.

Source: Economymiddleeast